Hope, quality of life, and benefit from treatment in women having chemotherapy for platinum-resistant/refractory recurrent ovarian cancer: the gynecologic cancer intergroup symptom benefit study.
about
Recommended patient-reported core set of symptoms to measure in adult cancer treatment trialsImpact of Recurrence of Ovarian Cancer on Quality of Life and Outlook for the Future.Prevalence and its associated psychological variables of symptoms of depression and anxiety among ovarian cancer patients in China: a cross-sectional study.Development of the Japanese version of an information aid to provide accurate information on prognosis to patients with advanced non-small-cell lung cancer receiving chemotherapy: a pilot study.
P2860
Hope, quality of life, and benefit from treatment in women having chemotherapy for platinum-resistant/refractory recurrent ovarian cancer: the gynecologic cancer intergroup symptom benefit study.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 09 October 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Hope, quality of life, and ben ...... ergroup symptom benefit study.
@en
Hope, quality of life, and ben ...... ergroup symptom benefit study.
@nl
type
label
Hope, quality of life, and ben ...... ergroup symptom benefit study.
@en
Hope, quality of life, and ben ...... ergroup symptom benefit study.
@nl
prefLabel
Hope, quality of life, and ben ...... ergroup symptom benefit study.
@en
Hope, quality of life, and ben ...... ergroup symptom benefit study.
@nl
P2093
P2860
P921
P1433
P1476
Hope, quality of life, and ben ...... ergroup symptom benefit study.
@en
P2093
Amit M Oza
Julie K Martyn
Kim Gillies
Madeleine T King
Martin R Stockler
Michael L Friedlander
Phyllis N Butow
Rachel L O'Connell
P2860
P304
P356
10.1634/THEONCOLOGIST.2013-0175
P577
2013-10-09T00:00:00Z